https://scholars.lib.ntu.edu.tw/handle/123456789/511376
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.author | Chen Y.-C. | en_US |
dc.contributor.author | Chiang C.-F. | en_US |
dc.contributor.author | Chen L.-F. | en_US |
dc.contributor.author | PO-CHIN LIANG | en_US |
dc.contributor.author | Hsieh W.-Y. | en_US |
dc.contributor.author | Win-Li Lin | en_US |
dc.date.accessioned | 2020-08-11T08:36:48Z | - |
dc.date.available | 2020-08-11T08:36:48Z | - |
dc.date.issued | 2014 | - |
dc.identifier.issn | 0142-9612 | - |
dc.identifier.uri | https://scholars.lib.ntu.edu.tw/handle/123456789/511376 | - |
dc.description.abstract | Chemotherapy for brain cancer tumors remains a big challenge for clinical medicine due to the inability to transport sufficient drug across the blood-brain barrier (BBB) and the poor penetration of drug into the tumors. To effectively treat brain tumors and reduce side effects on normal tissues, both des-octanoyl ghrelin and folate conjugated with polymersomal doxorubicin (GFP-D) was developed in this study to help transport across the BBB and target the tumor as well. The size measurements revealed that this BBB-penetrating cancer cell-targeting GFP-D was about 85nm. In-vitro experiments with a BBB model and C6 glioma cells demonstrated that GFP-D owned a robust penetrating-targeting function for drug delivery. In C6 cell viability tests, GFP-D exhibited an inhibitory effect significantly different from the unmodified polymersomal doxorubicin (P-D). In-vivo antitumor experiments showed that GFP-D performed a much better anti-glioma effect and presented a significant improvement in the overall survival of the tumor-bearing mice as compared to the treatments with free doxorubicin (Dox), liposomal doxorubicin (L-D), P-D, or single ligand conjugated P-D. In addition, Cy5.5 was used as a probe to investigate the delivery property of this penetrating-targeting delivery system. The overall experimental results indicate that this BBB-penetrating cancer cell-targeting GFP is a highly potential nanocarrier for the treatment of brain tumors. ? 2014 Elsevier Ltd. | - |
dc.relation.ispartof | Biomaterials | - |
dc.subject.classification | [SDGs]SDG3 | - |
dc.subject.other | Blood-brain barrier; Brain tumors; Cancer cell-targeting; Folate; Ghrelin; Blood; Brain; Cells; Chemotherapy; Drug delivery; Experiments; Medical nanotechnology; Polymers; Tumors; des octanoyl ghrelin folate polymersomal doxorubicin; doxorubicin; folic acid; ghrelin; unclassified drug; doxorubicin; folic acid; ghrelin; macrogol derivative; animal experiment; animal model; antineoplastic activity; article; blood brain barrier; brain tumor; cancer cell; cell viability; controlled study; cytotoxicity; drug conjugation; drug delivery system; drug penetration; drug transport; glioma cell; male; mouse; nonhuman; overall survival; priority journal; rat; therapy effect; analogs and derivatives; animal; Bagg albino mouse; blood brain barrier; chemistry; drug delivery system; glioma; metabolism; nude mouse; procedures; tumor cell line; Mus; Animals; Blood-Brain Barrier; Cell Line, Tumor; Doxorubicin; Drug Delivery Systems; Folic Acid; Ghrelin; Glioma; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Polyethylene Glycols; Rats | - |
dc.title | Polymersomes conjugated with des-octanoyl ghrelin and folate as a BBB-penetrating cancer cell-targeting delivery system | en_US |
dc.type | journal article | en |
dc.identifier.doi | 10.1016/j.biomaterials.2014.01.042 | - |
dc.identifier.pmid | 24513319 | - |
dc.identifier.scopus | 2-s2.0-84896727833 | - |
dc.relation.pages | 4066-4081 | - |
dc.relation.journalvolume | 35 | - |
dc.relation.journalissue | 13 | - |
item.cerifentitytype | Publications | - |
item.grantfulltext | none | - |
item.fulltext | no fulltext | - |
item.openairecristype | http://purl.org/coar/resource_type/c_6501 | - |
item.openairetype | journal article | - |
crisitem.author.dept | Radiology | - |
crisitem.author.dept | Medical Imaging-NTUH | - |
crisitem.author.dept | Medical Imaging-NTUHHC | - |
crisitem.author.orcid | 0000-0002-6674-2926 | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
crisitem.author.parentorg | NTU Hsin-Chu Hospital | - |
顯示於: | 醫學院附設醫院 (臺大醫院) |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。